Regular ArticleOverexpression of Interleukin-15 Induces Skeletal Muscle Hypertrophy in Vitro: Implications for Treatment of Muscle Wasting Disorders
References (52)
Cancer cachexia: Metabolic alterations and clinical manifestations
Nutrition
(1997)- et al.
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
Kidney Int.
(1999) The IGF-I receptor in cancer research
Exp. Cell Res.
(1999)- et al.
Double-stranded internucleosomal cleavage of apoptotic DNA is dependent on the degree of differentiation in muscle cells
J. Biol. Chem.
(1996) - et al.
Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats
Arch. Phys. Med. Rehabil.
(2001) - et al.
Evidence for the participation of the proteasome and calpain in early phases of muscle cell differentiation
Int. J. Biochem. Cell Biol.
(1998) - et al.
Distribution of protein turnover changes with age in humans as assessed by whole-body magnetic resonance image analysis to quantify tissue volumes
J. Nutr.
(2000) - et al.
Interleukin-15: Biology and relevance to human disease
Blood
(2001) Biology of cachexia
J. Natl. Cancer Inst.
(1997)Cachexia
Ann. Intern. Med.
(2000)
Skeletal muscle weakness in old age: Underlying mechanisms
Med. Sci. Sports Exercise
(1994)
The endocrinology of aging
Science
(1997)
One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women
J. Clin. Endocrinol. Metab.
(2001)
Increased mortality associated with growth hormone treatment in critically ill adults
N. Engl. J. Med.
(1999)
Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome
J. Clin. Endocrinol. Metab.
(1994)
Recombinant human growth hormone, insulin-like growth factor I, and combination therapy in AIDS-associated wasting
Ann. Intern. Med.
(1996)
Growth hormone replacement in healthy older men improves body composition but not functional ability
Ann. Intern. Med.
(1996)
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
J. Cell. Physiol.
(2000)
Role of the insulin-like growth factor family in cancer development and progression
J. Natl. Cancer Inst.
(2000)
The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy
J. Appl. Physiol.
(1996)
Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats
J. Appl. Physiol.
(1998)
Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation
Ann. Surg.
(2001)
Sarcopenia: current concepts
J. Gerontol. A Biol. Sci. Med. Sci.
(2000)
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
Science
(1994)
Interleukin-15: A novel anabolic cytokine for skeletal muscle
Endocrinology
(1995)
Cited by (166)
Exercise, mitochondrial dysfunction and inflammasomes in skeletal muscle
2024, Biomedical JournalMild heat stimulation facilitates muscle hypertrophy in C2C12 and mouse satellite cells through myokine release to the culture medium
2022, Biochemical and Biophysical Research CommunicationsMuscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression
2022, Biochimica et Biophysica Acta - Reviews on CancerSearching for the link between inflammaging and sarcopenia
2022, Ageing Research Reviews
- 1
To whom reprint requests should be addressed at 151 American Lake Division, VA Puget Sound Health Care System, Tacoma, WA 98493. E-mail: [email protected]. Fax: (253) 589-4004.
Copyright © 2002 Elsevier Science (USA). All rights reserved.